Since Piezo1 activation accelerates tumor growth and modulates the tumor microenvironment in pancreatic cancer, these findings suggest that Piezo channels, particularly Piezo1, have the potential to be novel therapeutic targets for drug design and treatment of GI tumors. The gene discussed is PIEZO1; the disease is familial pancreatic carcinoma.